Free Trial
NASDAQ:BBH

VanEck Biotech ETF (BBH) Price, Holdings, & News

VanEck Biotech ETF logo
$169.63
-2.72 (-1.58%)
(As of 10/31/2024 ET)

About VanEck Biotech ETF (NASDAQ:BBH)

Key Stats

Today's Range
$169.61
$170.85
50-Day Range
$170.87
$181.84
52-Week Range
$142.51
$183.64
Volume
3,358 shs
Average Volume
6,680 shs
Market Capitalization
$432.56 million
Assets Under Management
$434.45 million
Dividend Yield
0.42%
Net Expense Ratio
0.35%
Aggregate Rating
Moderate Buy

ETF Overview

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

VanEck Biotech ETF Expenses

TypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.35%0.56%0.55%0.49%0.52%
Other Expenses0.00%0.33%0.49%0.41%0.53%
Total Expense0.35%0.71%0.71%0.63%0.71%
Fee Waiver0.00%-0.45%-0.52%-0.32%-0.57%
Net Expense0.35%0.61%0.61%0.56%0.59%
Receive BBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

BBH ETF News Headlines

Are Rate Cuts Bad News For BIZD ETF?
Emphasize Consistency To Navigate Volatility
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.
3 Biotech ETFs for a Diversified Portfolio
See More Headlines

BBH ETF - Frequently Asked Questions

VanEck Biotech ETF's stock was trading at $165.31 at the beginning of 2024. Since then, BBH stock has increased by 2.9% and is now trading at $170.03.
View the best growth stocks for 2024 here
.

Top institutional shareholders of VanEck Biotech ETF include International Assets Investment Management LLC (44.76%), Pacific Sun Financial Corp (0.22%) and Creative Planning (0.07%).

Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Biotech ETF investors own include Meta Platforms (META), Micron Technology (MU), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), Adobe (ADBE) and Johnson & Johnson (JNJ).

Fund Details

Issuer
Van Eck
Fund Name
VanEck Biotech ETF
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:BBH
Inception Date
12/20/2011
Fund Manager
Hao-Hung Peter Liao, Guo Hua Jason Jin
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Market Vectors US Listed Biotech 25 Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
Global
Number of Holdings
26

Fund Statistics

Assets Under Management
$434.45 million
Average Daily Volume
$3,513.60
Discount/Premium
0.05%

Administrator, Advisor and Custodian

Administrator
Van Eck Associates Corporation
Advisor
Van Eck Associates Corporation
Custodian
State Street Bank and Trust Company
Distributor
Van Eck Securities Corporation
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
1,100 shs

Miscellaneous

Beta
0.85
Creation Unit
50,000
Creation Fee
$500.00
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

Top 10 BBH Holdings

BBH Sector Exposure

BBH Industry Exposure


This page (NASDAQ:BBH) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners